THC Biomed Brings Cigarettes to Cannabis

Cigarettes are coming to the cannabis sector. For now, however, they will remain to be purely cannabis, with no tobacco involved. THC Biomed International (CSE: THC) announced this morning that the company would become the first to offer a pure cannabis cigarette to the legal Canadian market.

Identifying that pre-rolls were one of the firms largest sales segments, THC made the move to expand into the pure cannabis cigarette market via the installation of an automated manufacturing line at its Acland Road facility. The equipment is capable of producing up to 5,000 cigarettes a minute according to the press release – indicating that should the segment really take off, THC is in an excellent position to capture a large portion of market share.

By now, many are likely curious what the difference between a ‘pure cannabis cigarette’ and a pre-roll is. The difference lies in the filter. Essentially, THC will be using filters originally destined for tobacco cigarettes, which allegedly provide a healthier alternative to consumption than pre-rolls.

“We promise our Pure Cannabis Cigarettes will offer the same potency as our regular best-selling pre-rolls. I am predicting consumers will gravitate towards this finished type of product and the old way of rolling joints will be something of the past,”

John Miller, President and CEO of THC BioMed

THC Biomed’s Pure Cannabis Cigarettes are to be sold in the standard pre-roll pack of 3, as well as a pack of 20 for the more frequent user. Four strains will initially be offered, three of which will be focused on THC consumption while the fourth is to be a CBD heavy strain.

THC Biomed indicated that the product will be available “soon” for both medical patients as well as through provincial distributors, but no set timeline was given.

Information for this briefing was found via Sedar and THC Biomed International. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.